Access personalized Castleman Disease Treatment care using advanced medical technology, supported by expert specialists and dedicated international patient services.
At Memorial Sisli Hospital, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 2000, the JCI, NABH accredited hospital is located in Istanbul, Turkey, and has 252 beds.
Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.
